Patent · US Active

Suppression of nuclear factor-κB dependent processes using oligonucleotides

US7655635B2 · kind B2 · utility

0Cited by
4References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 5, 2008
Grant dateFeb 2, 2010
Priority date—
Expiry dateMay 5, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/341
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Antisense oligonucleotides which hybridize with nuclear factor-κB (NF-κB) mRNA and methods of using these oligonucleotides.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.